Galectin Therapeutics Inc.
GALT
$1.32
$0.043.13%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/6/2025
-
MarketBeat
4/4/2025
-
MarketBeat
4/2/2025
-
TipRanks Financial Blog
4/1/2025
-
MarketBeat
4/1/2025
-
TipRanks Financial Blog
3/31/2025
-
GuruFocus
3/31/2025
-
The Fly
3/31/2025
-
Globe Newswire
3/28/2025
-
MarketBeat
3/14/2025
-
Simply Wall St
2/18/2025
-
The Fly
2/18/2025
-
GuruFocus
2/18/2025
-
Globe Newswire
2/4/2025
-
Ticker Report
1/15/2025
-
MarketBeat
1/10/2025
-
GuruFocus
1/10/2025
-
Globe Newswire
1/1/2025
-
Ticker Report
12/31/2024
-
MarketBeat
12/30/2024
-
MarketBeat
12/29/2024
-
Ticker Report
12/28/2024
-
Ticker Report
12/28/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
678 620 3186
Address
4960 Peachtree Industrial Boulevard
Norcross, GA 30071
Norcross, GA 30071
Country
Year Founded
Business Description
Sector
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead...
more
